| 000 | 01651nam a2200349 4500 | ||
|---|---|---|---|
| 001 | 6717 | ||
| 010 | _a9291680885 | ||
| 090 | _a6717 | ||
| 100 | _a20010326d2000 y0pory50 ba | ||
| 101 | _aeng | ||
| 200 |
_aUnderstanding and responding to drug use _ethe role of qualitative research _fEuropean Monitoring Centre for Drugs and Drug Addiction |
||
| 210 |
_aLuxembourg _cOffice for Official Publications of the European Communities _d2000 |
||
| 215 |
_a352 p. _cil. _d24 cm |
||
| 225 |
_aEMCDDA Scientific Monograph Series _v4 |
||
| 330 | _aForeword / Georges Estievenart. Genral introduction / Richard Hartnoll. I - The role of qualitative research. II - The impact of qualitative research on policy-making. III - New drug trends. IV - Risk behaviour. V - Social exclusion. VI - Drug markets. VII - Drug services evaluation. VIII - Methodological issues. IX - Qualitative research within a global research agenda. | ||
| 606 |
_aSAÚDE PÚBLICA _91370 |
||
| 606 |
_aCONSUMO DE DROGA _95102 |
||
| 606 |
_aTOXICODEPENDÊNCIA _94612 |
||
| 606 |
_aTIPOS DE DROGA _96299 |
||
| 606 |
_aCOMPORTAMENTO DE RISCO _96300 |
||
| 606 |
_aEXCLUSÃO SOCIAL _91364 |
||
| 606 |
_aUNIÃO EUROPEIA _9100 |
||
| 710 |
_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA _95764 |
||
| 852 | _jDRO217 | ||